Inflammation and Heart Diseases: Immunology, Cardiology,and Rheumatology,

Abstract

Disclosures: A. Abbate has received research support or consultant fees from CardiolRx, Implicit Biosciences, Kiniksa, Novo Nordisk, and Olatec; B. Weber reports scientific advisory board fees from Novo Nordisk, Kiniksa Pharmaceuticals, and Horizon Therapeutic. M. Garschick reports consultant fees for Kiniska, Agepha, BMS, and Horizon Therapeutics. L. Adamo has received consultant fees from Kiniksa and is co-founder of i-Cordis, LLC. C. Beavers has nothing to disclose.